✨ Free AI Report
Synektik Spólka Akcyjna: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Synektik Spólka Akcyjna
Company Research

Synektik Spólka Akcyjna: Business Overview, Financials & Competitive Analysis

Synektik Spólka Akcyjna scores 7/10 on the AskCyborg Cyborg Score (Solid). Synektik represents a profitable, dividend-paying niche player in Central European medical imaging with strong returns and cash generation, offering stable value exposure in a consolidating healthcare technology market. Synektik demonstrates solid operational performance with strong profitability metrics (18.33% operating margin), excellent returns on equity, and positive market momentum (39.58%.

What is Synektik Spólka Akcyjna's industry? Synektik Spólka Akcyjna (synektik.com.pl) operates in Medical Device Manufacturing & Healthcare IT Solutions. AskCyborg classifies Synektik Spólka Akcyjna under Medical Device Manufacturing & Healthcare IT Solutions in its company registry.

Synektik Spólka Akcyjna is a Polish medical technology company specializing in diagnostic imaging, nuclear medicine, and minimally invasive surgery solutions. The company operates as an integrated provider of medical ...

7/ 10Solid

Cyborg Score thesis

Synektik represents a profitable, dividend-paying niche player in Central European medical imaging with strong returns and cash...

Read the full analyst-debate transcript →
Industry Medical Device Manufacturing & Healthcare IT Solutions
3 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Synektik Spólka Akcyjna Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Synektik Spólka Akcyjna

AskCyborg analysts argue the bull and bear cases for Synektik Spólka Akcyjna across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Synektik Spólka Akcyjna OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Synektik Spólka Akcyjna Overview

Pro stress-test →

Synektik Spólka Akcyjna is a Polish medical technology company specializing in diagnostic imaging, nuclear medicine, and minimally invasive surgery solutions. The company operates as an integrated provider of medical equipment, PACS software, radiopharmaceuticals, and comprehensive support services to healthcare facilities across Central Europe.

Strategic Profile

Pro stress-test →

Synektik holds strategic advantages through its partnership with Siemens, its proprietary PACS software platform for diagnostic imaging laboratories, and its multi-country operational presence including Poland, Czech Republic, and Slovakia. The company benefits from strong financial metrics including a 51.78% ROE, solid cash generation with PLN 42.12 million in free cash flow, and a dividend yield of 4.18%, positioning it as a profitable, cash-generative healthcare solutions provider.

Competitive Landscape

Pro stress-test →

Synektik operates in the fragmented Central European medical imaging and diagnostic equipment market, competing against larger multinational firms like Siemens (its partner), Philips, and GE Healthcare. Its competitive advantages lie in specialized PACS software, localized service infrastructure, and partnerships that larger competitors cannot efficiently replicate in smaller markets. The company occupies a defensible niche serving regional healthcare institutions that value integrated solutions and personalized support.

Industry Context

Synektik Spólka Akcyjna operates in Medical Device Manufacturing & Healthcare IT Solutions.

Key facts

Headquarters: Warsaw, Poland · Revenue: PLN 592.94M · Market cap: PLN 1.69B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Synektik Spólka Akcyjna.

  • Strong profitability with 18.33% operating margin and 51.78% ROE indicates efficient capital deployment in a niche market
  • Siemens partnership provides competitive moat and market access for imaging solutions across Central Europe
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • July 2025Stock price increased 39.58% over 52-week period, demonstrating positive market momentum
  • 2025Maintained strong profitability with PLN 592.94 million revenue and PLN 83.22 million net profit over past 12 months
Get alerted when Synektik Spólka Akcyjna has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Synektik Spólka Akcyjna with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Synektik Spólka Akcyjna operates in Medical Device Manufacturing & Healthcare IT Solutions. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Device Manufacturing & Healthcare IT Solutions research →
NEW · MCP server

Ask your AI assistant about Synektik Spólka Akcyjna

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Synektik Spólka Akcyjna and its top competitor on Cyborg Score”
“What did Synektik Spólka Akcyjna do this quarter?”
“Is Synektik Spólka Akcyjna a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Synektik Spólka Akcyjna do?+
Synektik Spólka Akcyjna is a Polish medical technology company specializing in diagnostic imaging, nuclear medicine, and minimally invasive surgery solutions. The company operates as an integrated provider of medical ...
What is Synektik Spólka Akcyjna's Cyborg Score?+
Synektik Spólka Akcyjna has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Synektik Spólka Akcyjna's main competitors?+
Named competitors include Imaging Systems, Diagnostic Imaging Systems, Healthcare Diagnostics. The full competitive landscape is in the AskCyborg report.
How can I get the full Synektik Spólka Akcyjna research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Synektik Spólka Akcyjna research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Synektik Spólka Akcyjna over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual